|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bertuccio P, Chatenoud L, Levi F, Praud D,
Ferlay J, Negri E, Malvezzi M and La Vecchia C: Recent patterns in
gastric cancer: A global overview. Int J Cancer. 125:666–673. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Blum MA, Takashi T, Suzuki A and Ajani JA:
Management of localized gastric cancer. J Surg Oncol. 107:265–270.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rios P, Maruyama K, Sasako M, Sano T and
Katai H: The current situation and treatment strategy for gastric
cancer at the national cancer center of Tokyo, Japan. Rev
Gastroenterol Peru. 14:197–203. 1994.In Spanish.
|
|
6
|
Cidon EU, Ellis SG, Inam Y, Adeleke S,
Zarif S and Geldart T: Molecular targeted agents for gastric
cancer: A step forward towards personalized therapy. Cancers
(Basel). 5:64–91. 2013. View Article : Google Scholar
|
|
7
|
Varis A, Zaika A, Puolakkainen P, Nagy B,
Madrigal I, Kokkola A, Väyrynen A, Kärkkäinen P, Moskaluk C,
El-Rifai W and Knuutila S: Coamplified and overexpressed genes at
ERBB2 locus in gastric cancer. Int J Cancer. 109:548–553. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Califano D, Pignata S, Losito NS, Ottaiano
A, Greggi S, De Simone V, Cecere S, Aiello C, Esposito F, Fusco A
and Chiappetta G: High HMGA2 expression and high body mass index
negatively affect the prognosis of patients with ovarian cancer. J
Cell Physiol. 229:53–59. 2014.
|
|
9
|
Bi X, Rexer B, Arteaga CL, Guo M and
Mahadevan-Jansen A: Evaluating HER2 amplification status and
acquired drug resistance in breast cancer cells using Raman
spectroscopy. J Biomed Opt. 19:0250012014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li W, Tai Y, Zhou J, Gu W, Bai Z, Zhou T,
Zhong Z, McCue PA, Sang N, Ji JY, et al: Repression of endometrial
tumor growth by targeting SREBP1 and lipogenesis. Cell Cycle.
11:2348–2358. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koochekpour S, Majumdar S, Azabdaftari G,
Attwood K, Scioneaux R, Subramani D, Manhardt C, Lorusso GD,
Willard SS, Thompson H, et al: Serum glutamate levels correlate
with Gleason score and glutamate blockade decreases proliferation,
migration, and invasion and induces apoptosis in prostate cancer
cells. Clin Cancer Res. 18:5888–5901. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zadra G, Photopoulos C, Tyekucheva S,
Heidari P, Weng QP, Fedele G, Liu H, Scaglia N, Priolo C, Sicinska
E, et al: A novel direct activator of AMPK inhibits prostate cancer
growth by blocking lipogenesis. EMBO Mol Med. 6:519–538. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang CS, Matsuura K, Huang NJ, Robeson AC,
Huang B, Zhang L and Kornbluth S: Fatty acid synthase inhibition
engages a novel caspase-2 regulatory mechanism to induce ovarian
cancer cell death. Oncogene. 34:3264–3272. 2015. View Article : Google Scholar :
|
|
14
|
Jiang L, Xiao L, Sugiura H, Huang X, Ali
A, Kuro OM, Deberardinis RJ and Boothman DA: Metabolic
reprogramming during TGFβ1-induced epithelial-to-mesenchymal
transition. Oncogene. 34:3908–3916. 2015. View Article : Google Scholar :
|
|
15
|
Ogino S, Nosho K, Meyerhardt JA, Kirkner
GJ, Chan AT, Kawasaki T, Giovannucci EL, Loda M and Fuchs CS:
Cohort study of fatty acid synthase expression and patient survival
in colon cancer. J Clin Oncol. 26:5713–5720. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Dong L, Wei D, Wang X, Zhang S and
Li H: Fatty acid synthase mediates the epithelial-mesenchymal
transition of breast cancer cells. Int J Biol Sci. 10:171–180.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grube S, Dünisch P, Freitag D, Klausnitzer
M, Sakr Y, Walter J, Kalff R and Ewald C: Overexpression of fatty
acid synthase in human gliomas correlates with the WHO tumor grade
and inhibition with Orlistat reduces cell viability and triggers
apoptosis. J Neurooncol. 118:277–287. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Agostini M, Almeida LY, Bastos DC, Ortega
RM, Moreira FS, Seguin F, Zecchin KG, Raposo HF, Oliveira HC,
Amoêdo ND, et al: The fatty acid synthase inhibitor orlistat
reduces the growth and metastasis of orthotopic tongue oral
squamous cell carcinomas. Mol Cancer Ther. 13:585–595. 2014.
View Article : Google Scholar
|
|
19
|
Zaytseva YY, Rychahou PG, Gulhati P,
Elliott VA, Mustain WC, O'Connor K, Morris AJ, Sunkara M, Weiss HL,
Lee EY and Evers BM: Inhibition of fatty acid synthase attenuates
CD44-associated signaling and reduces metastasis in colorectal
cancer. Cancer Res. 72:1504–1517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tomek K, Wagner R, Varga F, Singer CF,
Karlic H and Grunt TW: Blockade of fatty acid synthase induces
ubiquiti-nation and degradation of phosphoinositide-3-kinase
signaling proteins in ovarian cancer. Mol Cancer Res. 9:1767–1779.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hou W, Fei M, Qin X, Zhu X, Greshock J,
Liu P, Zhou Y, Wang H, Ye BC and Qin CY: High overexpression of
fatty acid synthase is associated with poor survival in Chinese
patients with gastric carcinoma. Exp Ther Med. 4:999–1004.
2012.PubMed/NCBI
|
|
22
|
Ito T, Sato K, Maekawa H, Sakurada M,
Orita H, Shimada K, Daida H, Wada R, Abe M, Hino O and Kajiyama Y:
Elevated levels of serum fatty acid synthase in patients with
gastric carcinoma. Oncol Lett. 7:616–620. 2014.PubMed/NCBI
|
|
23
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
25
|
Wang L, Wu Y, Lin L, Liu P, Huang H, Liao
W, Zheng D, Zuo Q, Sun L and Huang N: Metastasis-associated in
colon cancer-1 upregulation predicts a poor prognosis of gastric
cancer, and promotes tumor cell proliferation and invasion. Int J
Cancer. 133:1419–1430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Swierczynski J, Hebanowska A and
Sledzinski T: Role of abnormal lipid metabolism in development,
progression, diagnosis and therapy of pancreatic cancer. World J
Gastroenterol. 20:2279–2303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hamada S, Horiguchi A, Asano T, Kuroda K,
Asakuma J, Ito K, Asano T, Miyai K and Iwaya K: Prognostic impact
of fatty acid synthase expression in upper urinary tract urothelial
carcinoma. Jpn J Clin Oncol. 44:486–492. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Walter K, Hong SM, Nyhan S, Canto M,
Fedarko N, Klein A, Griffith M, Omura N, Medghalchi S, Kuhajda F
and Goggins M: Serum fatty acid synthase as a marker of pancreatic
neoplasia. Cancer Epidemiol Biomarkers Prev. 18:2380–2385. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Horiguchi A, Asano T, Asano T, Ito K,
Sumitomo M and Hayakawa M: Fatty acid synthase over expression is
an indicator of tumor aggressiveness and poor prognosis in renal
cell carcinoma. J Urol. 180:1137–1140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Long QQ, Yi YX, Qiu J, Xu CJ and Huang PL:
Fatty acid synthase (FASN) levels in serum of colorectal cancer
patients: Correlation with clinical outcomes. Tumour Biol.
35:3855–3859. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Silva SD, Perez DE, Nishimoto IN, Alves
FA, Pinto CA, Kowalski LP and Graner E: Fatty acid synthase
expression in squamous cell carcinoma of the tongue:
Clinicopathological findings. Oral Dis. 14:376–382. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsuji T, Yoshinaga M, Togami S, Douchi T
and Nagata Y: Fatty acid synthase expression and
clinicopathological findings in endometrial cancer. Acta Obstet
Gynecol Scand. 83:586–590. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zaytseva YY, Elliott VA, Rychahou P,
Mustain WC, Kim JT, Valentino J, Gao T, O'Connor KL, Neltner JM,
Lee EY, et al: Cancer cell-associated fatty acid synthase activates
endothelial cells and promotes angiogenesis in colorectal cancer.
Carcinogenesis. 35:1341–1351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li N, Bu X, Tian X, Wu P, Yang L and Huang
P: Fatty acid synthase regulates proliferation and migration of
colorectal cancer cells via HER2-PI3K/Akt signaling pathway. Nutr
Cancer. 64:864–870. 2012. View Article : Google Scholar : PubMed/NCBI
|
